Atlas Trials

A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer

Clinical trial NCT06496724 · UNKNOWN

Trial details

NCT number
NCT06496724
Sponsor
JIANG LONGWEI
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-06-01
Primary completion
2025-06-30
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.